Upcoming events

Upcoming events

myNEO Therapeutics will attend job fairs and participate in the following events: J.P. Morgan Annual Healthcare Conference - Oral presentation - San Francisco - January 8 - 10, 2024 Keystone: Cancer ImmunoTherapy - Poster presentation - Whistler, Canada - March 17 -...

OUR LATEST POST

Happy Women’s Day

Today, on #internationalwomensday , we're proud to celebrate the remarkable women of myNEO Therapeutics. Their talent, dedication, and leadership are at the heart of our success. Thank you for your invaluable contributions! #womeninhealthcare

ALL POSTS

All

News

Press release

Article

Mar 8 2024

Happy Women’s Day

Today, on #internationalwomensday , we’re proud to celebrate the remarkable women of myNEO Therapeutics. Their talent, dedication, and leadershi...

Feb 15 2024

Training Session: the Cloud ImmunoEngine

Last week, our team came together for an engaging and informative training session about the cloud-based version of our ImmunoEngine led by Lore Van O...

Nov 22 2023

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

GHENT, Belgium and Tübingen, Germany/Boston, USA – November 22, 2023 – myNEO N.V. (myNEO Therapeutics) and CureVac N.V. (Nasdaq CVAC) announced t...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 25 2023

myNEO evolves into myNEO Therapeutics

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics. myNEO, a biotech company...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer a...

Mar 8 2024

Happy Women’s Day

Today, on #internationalwomensday , we’re proud to celebrate the remarkable women of myNEO Therapeutics. Their talent, dedication, and leadershi...

Feb 15 2024

Training Session: the Cloud ImmunoEngine

Last week, our team came together for an engaging and informative training session about the cloud-based version of our ImmunoEngine led by Lore Van O...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer a...

challenges_in_neoantigen_directed_therapeutics

Jun 1 2023

Review Trend in Cancer: Challenges in neoantigen-directed therapeutics

We are very happy to share our latest review paper! The power of personalized immunotherapy is becoming more and more apparent. The data pre...

May 1 2023

myNEO Tx academy launch

myNEO Therapeutics launches myNEO Tx academy on LinkedIn as we believe in the power of education! Each month we will touch upon a diffe...

Nov 22 2023

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

GHENT, Belgium and Tübingen, Germany/Boston, USA – November 22, 2023 – myNEO N.V. (myNEO Therapeutics) and CureVac N.V. (Nasdaq CVAC) announced t...

Oct 25 2023

myNEO evolves into myNEO Therapeutics

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics. myNEO, a biotech company...

Feb 13 2023

Odimma partners with myNEO Therapeutics for the clinical development of its personalized DNA-based cancer immunotherapy

Odimma Therapeutics and myNEO Therapeutics will partner to identify personalized targets for clinical development of DNA-based cancer vaccine therapy....

May 25 2022

CureVac Partners with myNEO Therapeutics to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

CureVac (Nasdaq: CVAC) and myNEO Therapeutics will partner to identify novel targets for mRNA-based cancer vaccine development. We’re convinced that...

Apr 7 2021

OncoDNA and myNEO Therapeutics Join Forces to Unlock the Power of Personalized Vaccines

Fighting Cancer with Personalized Vaccines: ONCODNA and myNEO Therapeutics collaboration OncoDNA, a company specializing in precision medicine, a...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer a...

Aug 1 2023

Bloovi interview

At myNEO Therapeutics we are devoted to finding new and better targets for immunotherapy. With our validated technology, our amazing te...

Nov 23 2022

Review publication in Cancer Cell

myNEO Therapeutics is extremely excited to announce the publication in the Cancer Cell journal, written by myNEO Therapeutics colleagues Lie...

Nov 14 2022

myNEO Therapeutics has won the 2022 Most Disruptive Innovator award

myNEO Therapeutics has won Deloitte’s 2022 Most Disruptive Innovator award. This award, which is part of the Rising Star category of the Deloitt...

Jun 21 2022

myNEO Therapeutics is growing its team and office

myNEO Therapeutics aims this year to double the team in size due to our growing project portfolio with multiple different partners. The data scie...

Innovating immunotherapies,
transforming tomorrow

Subscribe to our newsletter

Get the latest news & updates about myNEO Therapeutics

Home

About us

Products

Technology

Partners

Services

Contact

Quick links

Publications

Latest news

Privacy statement

Terms of use

Careers

Cookie statement

We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.

myNEO NV

Ottergemsesteenweg-Zuid 808 B511, 9000 Ghent, East-Flanders
Belgium (BE0715710837)

Design by